Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian CancerKelsey S Lau-Min, Anne Marie McCarthy, Katherine L Nathanson, et al.
Cancer|February 4, 2022
Association between timely targeted treatment and outcomes in patients with metastatic HER2-overexpressing gastroesophageal adenocarcinomaKelsey S Lau-Min, Yimei Li, Jennifer R Eads, et al.
JCO Oncology Practice|March 3, 2025
Management of Advanced Hepatocellular Carcinoma: A Review and Practical GuideVishnu Nagalapuram, Niveditha Popuri, Ryan D Nipp, et al.
JNCI Cancer Spectrum|October 15, 2025
Racial and ethnic differences in treatment and survival for hepatocellular carcinoma patients undergoing systemic therapyKelsey S Lau-Min, Angela C Tramontano, Franklin Iheanacho, et al.
JAMA Network Open|December 30, 2025
Treatment Patterns and Survival Outcomes Among Patients With Hepatocellular CarcinomaKelsey S Lau-Min, Angela C Tramontano, Franklin Iheanacho, et al.
Journal of the National Cancer Institute|May 15, 2024
Association between oral targeted cancer drug net health benefit, uptake, and spendingKelsey S Lau-Min, Yaxin Wu, Shavon Rochester, et al.
Cancer|March 17, 2021
Adherence to and determinants of guideline-recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practiceKelsey S Lau-Min, Yimei Li, Jennifer R Eads, et al.
Pharmacotherapy|September 28, 2020
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical ImplementationLisa A Varughese, Kelsey S Lau-Min, Christine Cambareri, et al.
BMC Cancer|January 8, 2022
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementationKelsey S Lau-Min, Lisa A Varughese, Maria N Nelson, et al.
The Oncologist|August 29, 2024
Telemedicine-based serious illness conversations, healthcare utilization, and end of life care among patients with advanced lung cancerTejaswini M Dhawale, Roopa S Bhat, P Connor Johnson, et al.
Pageof 3